UK ACUTE ONCOLOGY SOCIETY

Registered charity 1199351 · accounts filings on the Charity Commission register · also known as UKAOS

Provision of forum for Health Care professionals supporting emergency cancer care.Annual education programme.Website and educational resources.Supporting service innovation, shared learning and research promotion.

Objects

OBJECTSTHE OBJECTS OF THE CIO ARE:FOR THE PUBLIC BENEFIT, TO ADVANCE THE EDUCATION OF ALL HEALTHCARE PROFESSIONALS INVOLVED IN TREATING OR SUPPORTING PATIENTS IN THE FIELD OF ACUTE ONCOLOGY.IN FURTHERANCE OF THE OBJECT ABOVE, TO PROMOTE RESEARCH FOR THE PUBLIC BENEFIT IN ALL ASPECTS OF THAT SUBJECT AND TO PUBLISH THE USEFUL RESULTS.THE RELIEF OF SICKNESS AND PRESERVATION OF HEALTH, FROM CANCER. TO ASSIST IN THE TREATMENT AND CARE OF PERSONS SUFFERING FROM CANCER, OR IN NEED OF REHABILITATION, BY THE PROVISION OF EDUCATION FOR HEALTHCARE PROFESSIONALS.TO PROMOTE THE WELLBEING OF PEOPLE SUFFERING FROM ACUTE EFFECTS OF CANCER AND/OR ANTI-CANCER TREATMENT AND SUPPORT THE DEVELOPMENT OF ACUTE ONCOLOGY SERVICES THROUGH ASSISTING IN THE PROVISION OF EDUCATION.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: General Charitable Purposes · Education/training · The Advancement Of Health Or Saving Of Lives · Disability · website · Get email alerts

Latest income
£25k
Latest spending
£9k
Registered
2022
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity's gross income was less than £25,000 and it held no material debts at year-end. The trustees confirmed that the charity has adequate resources to continue its activities for the foreseeable future. No formal reserves policy was in place at the reporting date, with the trustees planning to develop one in 2026.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: BIOMERIEUX UK LTD (50% of income)
“BACS Payment Received – BIOMERIEUX UK LTD (00072000318198) 12500”
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Nepal · Northern Ireland · Scotland · Throughout England

Income and spending

Financial year endIncomeSpending
31/12/2025£25k£9k
31/12/2024£14k£23k
31/12/2023£20k£10k
31/12/2022£4k£0

Common questions

Is UK ACUTE ONCOLOGY SOCIETY financially healthy?

Per its FY2025 accounts: The accounts state that the charity's gross income was less than £25,000 and it held no material debts at year-end. The trustees confirmed that the charity has adequate resources to continue its activities for the foreseeable future. No formal reserves policy was in place at the reporting date, with the trustees planning to develop one in 2026. Its FY2025 accounts were independently examined.